{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:35:32Z","timestamp":1793352932411,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intracoronary glycoprotein IIb\/IIIa inhibitors (GPIs) after percutaneous coronary intervention (PCI) have shown better outcomes than intravenous administration. However, limited data exist comparing intracoronary versus intralesional GPI delivery during PCI for acute coronary syndromes (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, and the Cochrane Library were searched for randomized controlled trials comparing intralesional and intracoronary GPI administration in ACS patients undergoing PCI. Odds ratios (ORs) and mean differences were used to combine dichotomous and continuous outcomes, respectively, using a random-effects model. Analyses were conducted in RevMan 5.4 and CRAN-R.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine randomized controlled trials comparing the intralesional (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 509) with intracoronary route (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 486) were included. In the primary analysis, the intralesional route demonstrated significantly better postprocedural thrombolysis in myocardial infarction (TIMI) grade 3 flow [OR = 2.38, 95% confidence interval (CI) = 1.52\u20133.72,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001], corrected TIMI frame count (mean difference = \u22124.63, 95% CI = \u22128.83 to \u22120.43,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03), myocardial blush grade 3 (OR = 2.60, 95% CI = 1.51\u20134.49,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0006), and complete ST-segment resolution (OR = 1.64, 95% CI = 1.16\u20132.33,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005). After Hartung\u2013Knapp restricted maximum likelihood adjustment, only TIMI grade 3 flow remained significant (OR = 2.38, 95% CI = 1.36\u20134.15,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009). No significant differences were observed in major adverse cardiovascular events, bleeding, or thrombocytopenia (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>During PCI for ACS, intralesional GPI administration improves postprocedural TIMI grade 3 flow, with no significant differences in corrected TIMI frame count, complete ST-segment resolution, or hard clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001649","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:00:28Z","timestamp":1779865228000},"page":"580-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of intralesional versus intracoronary administration of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"37","author":[{"given":"Jawad","family":"Basit","sequence":"first","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushood","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Burhan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Foundation University School of Health Sciences, Islamabad"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"Zahra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hamza","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Guthrie Cortland Medical Center, Cortland, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London; Royal Brompton Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Kawsara","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, West Virginia University, Morgantown, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Daggubati","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, West Virginia University, Morgantown, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, West Virginia University, Morgantown, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Jagadeesan","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, West Virginia University, Morgantown, West Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Chadi","family":"Alraies","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,28]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review.","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"e008962","DOI":"10.1161\/CIRCINTERVENTIONS.120.008962","article-title":"Management of percutaneous coronary intervention complications: algorithms from the 2018 and 2019 Seattle percutaneous coronary intervention complications conference.","volume":"13","author":"Doll","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting.","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","article-title":"Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and\/or Resistance to Clopidogrel study.","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes.","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40292-023-00562-9","article-title":"An updated review on glycoprotein IIb\/IIIa inhibitors as antiplatelet agents: basic and clinical perspectives.","volume":"30","author":"Sharifi-Rad","year":"2023","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction\u2013executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjcard.2011.06.039","article-title":"Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome.","volume":"108","author":"Friedland","year":"2011","journal-title":"Am J Cardiol"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2011.11.053","article-title":"Meta-analysis of randomized controlled trials comparing intracoronary and intravenous administration of glycoprotein IIb\/IIIa inhibitors in patients with ST-elevation myocardial infarction.","volume":"109","author":"Wang","year":"2012","journal-title":"Am J Cardiol"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5603\/KP.a2015.0138","article-title":"Appropriate bolus administration of glycoprotein IIb\/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review.","volume":"74","author":"Ali-Hassan-Sayegh","year":"2016","journal-title":"Kardiol Pol"},{"key":"R13-20261030","doi-asserted-by":"crossref","first-page":"e8223","DOI":"10.1097\/MD.0000000000008223","article-title":"Intralesional versus intracoronary administration of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: a meta-analysis of randomized controlled trials.","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R14-20261030","first-page":"67","article-title":"The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; a randomized clinical trial study.","volume":"15","author":"Ghazal","year":"2019","journal-title":"ARYA Atheroscler"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.9734\/jammr\/2022\/v34i2031479","article-title":"Efficacy and safety of intracoronary administration of tirofiban through perforated balloon technique in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"34","author":"El-Ghlban","year":"2022","journal-title":"J Adv Med Med Res"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1542-474X.2007.00132.x","article-title":"Comparison of different methods of ST segment resolution analysis for prediction of 1\u2010year mortality after primary angioplasty for acute myocardial infarction.","volume":"12","author":"Przyluski","year":"2007","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/icr.2022.01","article-title":"Prognostic value of myocardial blush grade in ST-elevation MI: a systematic review and meta-analysis.","volume":"17","author":"Cruz","year":"2022","journal-title":"Interv Cardiol"},{"key":"R19-20261030","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing Summary of Findings tables - Binary outcomes.","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jrsm.1370","article-title":"Random-effects meta-analysis of few studies involving rare events.","volume":"11","author":"G\u00fcnhan","year":"2020","journal-title":"Res Synth Methods"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/sim.7411","article-title":"The Hartung\u2010Knapp modification for random\u2010effects meta\u2010analysis: a useful refinement but are there any residual concerns?","volume":"36","author":"Jackson","year":"2017","journal-title":"Stat Med"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00228-025-03869-9","article-title":"Efficacy and safety of colchicine post myocardial infarction: a systematic review, meta-analysis and meta-regression analysis of randomized clinical trials.","volume":"81","author":"Naeem","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"e10850","DOI":"10.1097\/MD.0000000000010850","article-title":"Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"B92","DOI":"10.1016\/j.jacc.2016.09.277","article-title":"TCT-226 thrombus aspiration for ocluded coronary artery enhanced with distal injection of abciximab (TOLEDO 1).","volume":"68","author":"Burgos","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jcin.2010.05.017","article-title":"Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes.","volume":"3","author":"Prati","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ahj.2015.08.020","article-title":"Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.","volume":"170","author":"Prati","year":"2015","journal-title":"Am Heart J"},{"key":"R31-20261030","first-page":"1123","article-title":"Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion in patients with acute ST-segment elevation myocardial infarction.","volume":"13","author":"Tang","year":"2015","journal-title":"Chinese J Cardiovasc Res"},{"key":"R32-20261030","first-page":"70","article-title":"Effect of tirofiban injection from thrombus aspirating catheter in patients with acute myocardial infarction during primary percutaneous coronary intervention with no-reflow.","volume":"12","author":"Fu","year":"2015","journal-title":"Chinese J Interv Imaging Ther"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2014.06.1194","article-title":"Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction.","volume":"64","author":"Eitel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R34-20261030","first-page":"369","article-title":"Microvascular obstruction after percutaneous coronary intervention.","volume":"75","author":"Lee","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jcin.2010.05.004","article-title":"Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.","volume":"3","author":"Jaffe","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/hrt.2003.020800","article-title":"Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.","volume":"90","author":"Galiuto","year":"2004","journal-title":"Heart"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/01.CIR.0000127812.62277.50","article-title":"Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging.","volume":"109","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/eurheartj\/ehi147","article-title":"Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging.","volume":"26","author":"Hombach","year":"2005","journal-title":"Eur Heart J"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":"Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.","volume":"36","author":"Morishima","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R40-20261030","first-page":"641","article-title":"Intralesional delivery of glycoprotein IIb\/IIIa inhibitors in acute myocardial infarction: review and recommendations.","volume":"99","author":"Kirresh","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.","volume":"14","author":"Inthout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"Suppl 2","key":"R42-20261030","article-title":"Comparison between intracoronary versus intravenous bolus injection of tirofiban on infarct size during primary PCI in patients with acute anterior ST segment elevation myocardial infarction.","volume":"41","author":"Osman","year":"2020","journal-title":"Eur Heart J"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-006-9000-0","article-title":"Rationale for intracoronary administration of abciximab.","volume":"23","author":"Romagnoli","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCINTERVENTIONS.108.847996","article-title":"A comparison of abciximab and small-molecule glycoprotein IIb\/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.","volume":"2","author":"Gurm","year":"2009","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:01:09Z","timestamp":1793350869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,28]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001649","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,28]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}